Genes governing premature ovarian failure

Reproductive BioMedicine Online

Volumn 20, Issue 6, 2010, Pages 724-740

  Dixit, Hridesh ^a   Rao, Lakshmi ^a   Padmalatha, Venkata ^a   Raseswari, Turlapati ^a   Kapu, Anil Kumar ^a   Panda, Bineet ^a   Murthy, Kanakavalli ^a   Tosh, Durgadutta ^a   Nallari, Pratibha ^b   Deenadayal, Mamata ^c   Gupta, Nalini ^d   Chakrabarthy, Baidyanath ^d   Singh, Lalji ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b OSMANIA UNIVERSITY   (India)

^c Infertility Institute and Research Centre   (India)

^d Institute of Reproductive Medicine   (India)

Author keywords

Candidate genes; Chromosome abnormalities; Ovarian dysgenesis; Ovarian physiology; Premature ovarian failure

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ACTIVIN; AROMATASE; ATM PROTEIN; AUTOIMMUNE REGULATOR PROTEIN; BONE MORPHOGENETIC PROTEIN 15; CONNEXIN 37; ESTRADIOL; FOLLITROPIN; FOLLITROPIN BETA SUBUNIT; FOLLITROPIN RECEPTOR; FRAGILE X MENTAL RETARDATION PROTEIN; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GROWTH DIFFERENTIATION FACTOR 9; LUTEINIZING HORMONE; NERVE GROWTH FACTOR; PROTEIN BCL 2; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE 17BETA DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1;

BLEPHAROPHIMOSIS; CELL MIGRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION X; CHROMOSOME XQ; CLINICAL PRACTICE; FEMALE INFERTILITY; GALACTOSEMIA; GENE; GENE MUTATION; GENETIC ASSOCIATION; GERM CELL; HUMAN; NONHUMAN; PREMATURE OVARIAN FAILURE; PTOSIS; REVIEW; STEROIDOGENESIS;

EID: 77957803514     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.02.018     Document Type: Review

References (103)

1. Aittomaki, K., Herva, R., Stenman, U.H., et al., 1996. Clinical features of primary ovarian failure caused by a point mutation in the follicle stimulating hormone receptor gene. J. Clin. Endo-crinol. Metab. 81, 3722-3726.
2. Aittomaki, K., Lucena, J.L.D., Pakarinen, P., et al., 1995. Mutation in the follicle stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82, 959-968.
3. Allingham-Hawkins, D.J., Babul-Hirji, R., Chitayat, D., et al., 1999. Fragile X-premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study-preliminary data. Am. J. Med. Genet. 83, 322-325.
4. Anil, K.K., Lakshmi, R., Suryanarayana, V.V., et al., 2005. Screening of galactose-1-phosphate uridyltransferase gene in Indian women with ovarian failure. Reprod. Biomed. Online 11, 444-448.
5. Ashraf, M., Jayawickrama, N.S., Bowen-Simpkins, P., 2001. Premature ovarian failure due to an unbalanced translocation on the X chromosome. Br. J. Obstet. Gynaecol. 108, 230-232.
6. Banerzee, N., Kriplani, A., Takkar, D., et al., 1997. Balanced X: 22 translocation in a patient with premature ovarian failure. Acta Genet. Med. Gemellol. (Roma) 46, 241-244.
7. Beau, I., Touraine, P., Meduri, G., et al., 1998. A novel phenotype related to partial loss of function mutation of the follicle stimulating hormone receptor. J. Clin. Invest. 102, 1352-1359.
8. Bione, S., Sala, C., Manzini, C., et al., 1998. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implication for human sterility. Am. J. Hum. Genet. 62, 533-541.
9. Bose, H.S., Pesconitz, O.H., Miller, W.L., 1997. Spontaneous feminization in a 46 XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in a steroidogenec acute regulatory protein. J. Clin. Endocrinol. Metab. 82, 1511-1515.
10. Bousquet, D., Léveillé, M.C., et al., 2005. The cellular origin of the zona pellucida antigen in the human and hamster. J. Exp. Zool. 215, 215-218.
11. Chapman, S.C., Woodruff, T.K., 2003. Betaglycan localization in the female rat pituitary: implications for the regulation of FSH by inhibin. Endocrinology 144, 5640-5649.
12. Conte, F.A., Grumbach, M.M., Ito, Y., et al., 1994. A syndrome of female pseudohermaphrodism hypergonadotropic hypogonadism and multicystic ovaries associated with missence mutation in the gene encoding aromatase (P450arom). J. Clin. Endocrinol. Metab. 78, 1287-1292.
13. Conway, G.S., Payne, N.N., Webb, J., et al., 1998. Fragile X-premutation screening in women with premature ovarian failure. Hum. Reprod. 13, 1184-1187. (Pubitemid 28279167)
14. Coulam, C.B., Adamson, S.C., Annegers, J.F., 1986. Incidence of premature ovarian failure. Obstet. Gynecol. 67, 60-66.
15. Crisponi, L., Deiana, M., Loi, A., et al., 2001. The putative forkhead transcription factor FOXL2 is mutated in blepharophi-mosis/ptosis/epicanthus/ inversus syndrome. Nat. Genet. 27, 159-166.
16. Cronister, A., Schrenier, R., Wittenberger, M., et al., 1991. Heterozygous fragile X-female: historical, physical, cognitive and cytogenetic features. Am. J. Med. Genet. 38, 269-274.
17. Davidson, R.M., Fox, M., Conway, G.S., 2000. Mapping of the POF1 locus and identification of putative genes for premature ovarian failure. Mol. Hum. Reprod. 6, 314-318.
18. Davidson, R.M., Quilter, C.R., Webb, J., et al., 1998. A familial case of X-chromosome deletion ascertained by cytogenetic screening of women with premature ovarian failure. Hum. Reprod. 13, 3039-3041.
19. Davis, C.J., Davison, R.M., Payne, N.N., et al., 2000. Female sex preponderance for idiopathic familial premature ovarian failure suggestsan X-chromosome defect. Hum. Reprod. 15, 2418-2422.
20. De Baere, E., Roy, N.V., Speleman, F., et al., 1999. Closing in on the BPES gene on 3q23: mapping of a de novo reciprocal translocation t (3:4) (q23; p15.2) breakpoints within a 45 kb cosmid and mapping of three candidate genes, RBP-1, RBP-2, b-COP, distal to the breakpoint. Genomics 57, 70-78.
21. De Roux, N., Young, J., Misrahi, M., et al., 1997. A family with hypogonadotropic hypogonadism and mutations in the gonado-tropin release hormone receptor. N. Engl. J. Med. 337, 1597-1602.
22. Di Pasquale, E., Beck-Peccoz, P., Persani, L., 2004. Hypergonad-otropic ovarian failure associated with an inherited mutation of Human Bone Morphogenetic protein-15 (BMP15) gene. Am. J. Hum. Genet. 75, 106-111.
23. Dissen, G.A., Newman, H.A., Malamed, S., et al., 1995. Expression of neurotrophins and their receptors in the mammalian ovary is developmentally regulated: changes at the time of folliculogen-esis. Endocrinology 136, 4681-4692.
24. Dissen, G.A., Romero, C., Newman, H.A., 2001. Nerve Growth Factor is required for early follicular development in the Mammalian Ovary. Endocrinology 142, 2078-2086.
25. Dixit, H., Deendayal, M., Singh, L., 2004. Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum. Reprod. 19, 1760-1764.
26. Dixit, H., Rao, K.L., Padmalatha, V.V., et al., 2005. Mutational screening of coding region of Growth Differentiation Factor 9 gene in Indian women with ovarian failure. Menopause 119, 749-754.
27. Dixit, H., Rao, K.L., Padmalatha, V.V., et al., 2006a. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum. Genet. 11, 408-415.
28. Dixit, H., Rao, K.L., Padmalatha, V.V., et al., 2006b. Mutational analysis of the betaglycan gene coding region in susceptibility for ovarian failure. Hum. Reprod. 21, 2041-2046.
29. Doherty, E., Pakarinen, P., Tiitinen, A., et al., 2002. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J. Clin. Endocrinol. Metab. 87, 1151-1155.
30. Dong, J., Albertini, D.F., Nishimori, K., et al., 1996. Growth differentiation factor is required during early ovarian folliculo-genesis. Nature 383, 531-535.
31. Dorrington, J.H., Bendell, J.J., Khan, S.A., 1993. Interactions between FSH, estradiol-17b and transforming growth factor-b regulate growth and differentiation in the rat gonad. J. Steroid Biochem. Mol. Biol. 44, 441-447.
32. Filicori, M., 1999. The role of luteinizing hormone in folliculogen-esis and ovulation duction. Fertil. Steril. 71, 405-414.
33. Fitch, N., De Saint, V.J., Richer, C.L., et al., 1982. Premature menopause due to a small deletion in the long arm of X-chromosome. Am. J. Obstet. Gynecol. 142, 968-972.
34. Furui, K., Suganuma, N., Tsukahara, S.-I., et al., 1994. Identification of point mutations in the gene coding luteinizing hormone (LH) b-subunit, associated with immunologically anomalous LH variant. J. Clin. Endocrinol. Metab. 78, 107-113.
35. Galloway, S.M., McNatty, K.P., Cambridge, L.M., et al., 2000. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat. Genet. 25, 279-283.
36. Gougeon, A., 1996. Regulation of ovarian follicular development in primates: facts and hypothesis. Endocrinol. Rev. 17, 121-155.
37. Gromoll, J., Gudermann, T., Greshniok, A., et al., 1999. Male psuedohermaphroditism due to an inactivating mutation in the extracellular domain of the luteinizing hormone receptor. Exp. Clin. Endocrinol. Diabetes 107 (Suppl. 1), 10.
38. Guerrero, N.V., Singh, R.H., Manatunga, A., 2000. Risk factors for premature ovarian failure in females with galactosemia. J. Pediatr. 137, 833-841.
39. Guillemin, Y., Lalle, P., Gillet, G., et al., 2009. Oocytes and early embryos selectively express the survival factor BCL2L10. J. Mol. Med. 87, 923-940.
40. Harris, S.E., Chand, A.L., Winship, I.M., et al., 2002. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol. Hum. Reprod. 8, 729-733.
41. Hens, L., Devroey, P., Van Waesberghe, L., et al., 1995. Chromosome studies and fertility treatment in women with ovarian failure. Cell 82, 959-968.
42. Hillier, S.G., 1994. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum. Reprod. 9, 188-191.
43. Hsuesh, A.J., Dahl, K.D., Vaughan, J., et al., 1987. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone stimulated androgen biosynthesis. Proc. Natl. Acad. Sci. USA 84, 5082-5086.
44. Hundscheid, R.D.L., Sistermans, E.A., Thomas, C.M.G., et al., 2000. Imprinting effect in premature ovarian failure confined to paternally inherited Fragile X Premutations. Am. J. Hum. Genet. 66, 413-418.
45. 566C fi T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time resolved fluorome-try. J. Clin. Endocrinol. Metab. 83, 4338-4343.
46. Kaipia, A., Hsueh, A.J., 1997. Regulation of ovarian follicular atresia. Annu. Rev. Physiol. 59, 349-353.
47. Kaufman, F.R., Xu, Y.K., Ng, W.G., et al., 1989. Gonadal function and ovarian galactose metabolism in classic galactosemia. Acta Endocrinol. (Copenh) 120, 129-133.
48. Kawano, Y., Narahara, H., Matsui, N., et al., 1998. Premature ovarian failure associated with a robertsonian translocation. Acta Obstet. Gynecol. Scand. 77, 467-469.
49. Kohek, M.B.D.F., Batista, M.C., Russell, A.J., et al., 1998. No evidence of the inactivating mutation (C566T) in the follicle stimulating hormone receptor gene in Brazilian women with premature ovarian failure. Fertil. Steril. 70, 565-567.
50. Krauss, C.M., Turksoy, N., Atkins, L., et al., 1987. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X-chromosome. N. Engl. J. Med. 317, 125-131.
51. Lara, H.E., McDonald, J.K., Ojeda, S.R., 1990. Involvement of nerve growth factor in female sexual development. Endocrinology 126, 364-375.
52. Latronico, A.C., Anasti, J., Arnhold, I.J.P., et al., 1996. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutation of the luteinizing hormone receptor gene. N. Engl. J. Med. 334, 507-512.
53. Latronico, A.C., Chai, Y., Arnhold, I.J., et al., 1998. A homozy-gous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol. Endocrinol. 12, 442-450.
54. Layman, L.C., 1991. The genetics of gonadotropin genes and the GnRH/GAP gene. Semin. Reprod. Endocrinol. 9, 22-23.
55. Layman, L.C., 2002. Human gene mutations causing infertility. J. Med. Genet. 39, 153-161.
56. Layman, L.C., Amde, S., Cohen, D.P., et al., 1998. The Finnish follicle stimulating hormone receptor (FSHR) gene mutation in women with 46,XX ovarian failure is rare in the United States. Fertil. Steril. 69, 300-302.
57. Layman, L.C., Lee, L.J., Peak, D.B., et al., 1997. Delayed puberty and hypogonadism caused by a mutation in the follicle stimulating hormone beta-subunit gene. N. Engl. J. Med. 337, 607-611.
58. Lin, D., Sugawara, T., Strauss III, J.F., et al., 1995. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267, 1828-1831.
59. Luoh, S.W., Bain, P.A., Polakiewicz, R.D., et al., 1997. Zfx mutation results in small animal size and reduces germ cell number in male and female mice. Development 124, 2275-2284.
60. Marozzi, A., Porta, C., Vegetti, W., et al., 2002. Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum. Reprod. 17, 1741-1745.
61. Marozzi, A., Vegetti, W., Manfredini, E., et al., 2000. Association between idiopathic premature ovarian failure and fragile X premutation. Hum. Reprod. 15, 197-202.
62. Matsuda-Minehata, F., Inoue, N., Goto, Y., et al., 2006. The regulation of ovarian granulosa cell death by pro-and anti-apoptotic molecules. J. Reprod. Dev. 52, 695-705.
63. Matthews, C.H., Borgato, S., Beck-Peccoz, P., et al., 1993. Primary amenorrhoea and infertility due to a mutation in the b subunit of follicle stimulating hormone. Nat. Genet. 5, 83-86.
64. Matzuk, M.M., Burns, K.H., Viveiros, M.M., et al., 2002. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296, 2178-2180.
65. Matzuk, M.M., Finegold, M.J., Mather, J.P., et al., 1994. Development of cancer cachexia-like syndrome and adrenal tumour in inhibin-deficient mice. Proc. Natl. Acad. Sci.USA 91, 8817-8821.
66. Matzuk, M.M., Finegold, M.J., Su, J.G.J., et al., 1992. a-Inhibin is a tumour suppressor gene associated with gonadal specificity in mice. Nature 360, 313-319.
67. McLaughlin, E.A., McIver, S.C., 2009. Awakening the oocyte: controlling primordial follicle development. Reproduction 137, 1-11.
68. McNatty, K.P., Smith, P., Moore, L.G., et al., 2005. Oocyte-expressed genes affecting ovulation rate. Mol. Cell Endocrinol. 234, 57-66.
69. Melissa, E.P., 2006. From primordial germ cell to primordial follicle: mammalian female germ cell development. Genesis 44, 622-632.
70. Moore, R.K., Erickson, G.F., Shimasaki, S., 2004. Are BMP-15 and GDF-9 primary determinants of ovulation quota in mammals? Trends Endocrinol. Metab. 15, 356-361.
71. Morgante, A.M.V., Costa, S.S., 2000. Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X. Am. J. Hum. Genet. 67, 254-255.
72. Morishima, A., Grumbach, M.M., Simpson, E.R., et al., 1995. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80, 3689-3698.
73. Murray, A., Ennis, S., Morton, N., 2000. No evidence for parent of origin influencing premature ovarian failure in fragile X premu-tation carriers. Am. J. Hum. Genet. 67, 253-254.
74. Murray, A., Webb, J., Dennis, N., et al., 1999. Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J. Med. Genet. 36, 767-770.
75. Murray, A., Webb, J., Grimley, S., et al., 1998. Studies of FRAXA and FRAXE in women with premature ovarian failure. J. Med. Genet. 35, 637-640. (Pubitemid 28371973)
76. Naguib, K.K., Sunderesan, T.S., Bahar, A.M., et al., 1988. Fertility with deletion Xq25: report of three cases; possible exception for critical region hypothesis. Fertil. Steril. 49, 917-919.
77. Nilsson, C., Petterson, K., Millar, R.P., 1997. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. Fertil. Steril. 67, 998-1004.
78. O, W.S., Robertson, D.M., De Kretser, D.M., 1989. Inhibin as an oocyte meiotic inhibitor. Mol. Cell Endocrinol. 62, 307-311.
79. Ogata, T., Hasegawa, T., Tamai, S., et al., 1998. Hypergonado-tropic hypogonadism in a 3 years old girl with Blepharophimosis Ptosis Epicanthus Inversus syndrome. Horm. Res. 50, 190-192.
80. Otsuka, F., Yao, Z., Lee, T., Yamamoto, S., Erickson, G.F., Shimasaki, S., 2000. Bone morphogenetic protein-15 identification of target cells and biological functions. J. Biol. Chem. 275, 39523-39528.
81. Phillips, D.J., Woodruff, T.K., 2004. Inhibin: action and signalling. Growth Factors 22, 13-18.
82. Powell, C.M., Taggart, R.T., Drumheller, T.C., et al., 1994. Molecular and cytogenetic studies of an X: autosome translocation in a patient with premature ovarian failure and review of the literature. Am. J. Med. Genet. 52, 19-26.
83. Praphanphoj, V., Goodman, B.K., Thomas, G.H., 2000. Molecular cytogenetic evaluation in a patient with a translocation (3:21) associated with Blepherophimosis Ptosis Epicanthus Inversus syndrome. Genomics 65, 67-69.
84. Rabin, D., Spitz, I., Bercovici, B., et al., 1972. Isolated deficiency of follicle stimulating hormone: clinical and laboratory features. N. Engl. J. Med. 287, 1313-1317.
85. Rabinovici, J., Spencer, S.J., Jaffe, R.B., 1990. Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. J. Clin. Endocrinol. Metab. 71, 1396-1398.
86. Ratts, V.S., Flaws, J.A., Kolp, R., et al., 1995. Ablation of bcl-2 gene expression decreases the number of oocytes and primordial follicles established in the postnatal female mouse gonad. Endocrinology 136, 3665-3668.
87. Royzman, I., Austin, R.J., Bosco, G., et al., 1999. ORC localization in Drosophila follicle cells and the effect of mutations in DE2F and dDP genes. Development 13, 471-481.
88. Sala, C., Arrigo, G., Martinazzi, F., et al., 1997. Eleven chromosome breakpoint associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21. Genomics 40, 123-131.
89. Shelling, A.N., Burton, K.A., Chand, A.L., et al., 2000. Inhibin: a candidate gene for premature ovarian failure. Hum. Reprod. 15, 2644-2649.
90. Simon, A.M., Goodenough, D.A., Li, E., et al., 1997. Female infertility in mice lacking connexin 37. Nature 385, 525-529.
91. Sreenivasulu, G., Senthilkumaran, 2009. A role foe cytochrome P450 17a hydroxylase/c17-20lyase during shift in steriodogen-esis occurring in ovarian follicles prior to oocyte maturation. J. Steroid Biochem. Mol. Biol. 115, 77-85.
92. Takabayashi, K., Takakura, K., Wang, H.Q., et al., 2000. Mutation analysis of the growth differentiation factor-9 and-9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil. Steril. 74, 976-979.
93. Tharapel, A.T., Anderson, K.P., Simpson, J.L., et al., 1993. Deletion (X) (q26.1→q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions. Am. J. Med. Genet. 52, 463-471.
94. Therman, E., Laxova, R., Susman, B., 1990. The critical region on the human Xq. Effect caused by Xp and Xq deletions in the human female: a hypothesis. Hum. Genet. 85, 455-461.
95. Thomson, J.R., Machado, R.D., Pauciulo, M.W., et al., 2000. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-b family. J. Med. Genet. 37, 741-745.
96. Toledo, S.P.A., Brunner, H.G., Kraaji, R., et al., 1996. An activating mutation of the luteinizing hormone receptor causes amenorrhoea in a 46, XX female. J. Clin. Endocrinol. Metab. 81, 3850-3854.
97. Touraine, P., Beau, I., Gougeon, A., et al., 1999. New natural inactivating mutations of the follicle stimulating hormone receptor: correlation between receptor function and phenotype. Mol. Endocrinol. 13, 1844-1854.
98. Veggeti, W., Tibiletti, M.G., Testa, G., et al., 1998. Inheritance in idiopathic premature ovarian failure analysis of 71 cases. Hum. Reprod. 13, 1796-1800.
99. Veneman, T.F., Beverstock, G.C., Exalto, N., et al., 1991. Premature menopause because of an inherited deletion in the long arm of the X-chromosome. Fertil. Steril. 55, 631-634.
100. Vitt, U.A., McGee, E.A., Hayashi, M., et al., 2000. In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 141, 3814-3820.
101. Weinstein, L.S., Shenker, A., Gejman, P.V., et al., 1991. Activating mutations of a stimulatory G protein in the McCune Albright syndrome. N. Engl. J. Med. 325, 1688-1695.
102. Woodruff, T.K., Mayo, K.E., 1990. Regulation of inhibin synthesis in the rat ovary. Annu. Rev. Physiol. 52, 807-821.
103. Zinn, A.R., Page, D.C., Fisher, E.M., 1993. Turner syndrome: the case of the missing sex chromosome. Trends Genet. 9, 90-93.